Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: Results from the REPRISE II trial with extended cohort.

MLA

Houle V.M., et al. Insights into the Need for Permanent Pacemaker Following Implantation of the Repositionable LOTUS Valve for Transcatheter Aortic Valve Replacement in 250 Patients: Results from the REPRISE II Trial with Extended Cohort. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305138784&authtype=sso&custid=ns315887.

APA

Houle V.M., Dawkins K.D., Dumonteil N., Meredith I.T., Blackman D.J., Tchetche D., Hildick-Smith D., Allocco D.J., Spence M.S., Walters D.L., Harnek J., Worthley S.G., Rioufol G., Lefevre T., Modine T., & Van Mieghem N. (2017). Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: Results from the REPRISE II trial with extended cohort.

Chicago

Houle V.M., Dawkins K.D., Dumonteil N., Meredith I.T., Blackman D.J., Tchetche D., Hildick-Smith D., et al. 2017. “Insights into the Need for Permanent Pacemaker Following Implantation of the Repositionable LOTUS Valve for Transcatheter Aortic Valve Replacement in 250 Patients: Results from the REPRISE II Trial with Extended Cohort.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305138784&authtype=sso&custid=ns315887.